BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30816328)

  • 1. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
    Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
    Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
    Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
    Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
    Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
    Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
    Tsuchiya KD; Davis B; Gardner RA
    Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
    Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
    Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
    Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
    Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia.
    Harrison CJ; Schwab C
    Eur J Med Genet; 2016 Mar; 59(3):162-5. PubMed ID: 26836400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
    Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
    Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
    J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
    Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
    Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.
    Trinquand A; Betts DR; Harte S; Sills A; Rooney S; Barrett N; Storey L; Malone A; O'Marcaigh A; Smith OP
    Leuk Lymphoma; 2024 Feb; 65(2):279-282. PubMed ID: 37909291
    [No Abstract]   [Full Text] [Related]  

  • 12. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
    Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
    J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.
    Ding XJ; Liu MX; Ao L; Liang YR; Cao Y
    Virchows Arch; 2011 May; 458(5):561-9. PubMed ID: 21279520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.
    Harrison CJ
    Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
    Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
    Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
    Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
    Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the RAS pathway in iAMP21-ALL.
    Ryan SL; Matheson E; Grossmann V; Sinclair P; Bashton M; Schwab C; Towers W; Partington M; Elliott A; Minto L; Richardson S; Rahman T; Keavney B; Skinner R; Bown N; Haferlach T; Vandenberghe P; Haferlach C; Santibanez-Koref M; Moorman AV; Kohlmann A; Irving JA; Harrison CJ
    Leukemia; 2016 Sep; 30(9):1824-31. PubMed ID: 27168466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired uniparental isodisomies involving chromosome 12 in paediatric B-cell precursor acute lymphoblastic leukaemia: Associations with chromosome 21 gains and SH2B3 mutations.
    Lundin-Ström KB; Biloglav A; Castor A; Olsson-Arvidsson L; Johansson B
    Br J Haematol; 2023 May; 201(3):585-588. PubMed ID: 36899493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.